[
  {
    "id": "NCT001",
    "title": "Phase 3 Study of Pembrolizumab in NSCLC",
    "conditions": ["Non-Small Cell Lung Cancer", "Lung Cancer", "NSCLC"],
    "inclusion_criteria": "Age >= 18, Histologically confirmed NSCLC, PD-L1 positive",
    "exclusion_criteria": "Autoimmune disease, recent chemotherapy",
    "phase": "Phase 3"
  },
  {
    "id": "NCT002",
    "title": "Metformin for Type 2 Diabetes Management",
    "conditions": ["Type 2 Diabetes", "Diabetes Mellitus"],
    "inclusion_criteria": "Age 18-75, HbA1c > 7.0%, BMI > 25",
    "exclusion_criteria": "Kidney disease, Liver disease",
    "phase": "Phase 4"
  },
  {
    "id": "NCT003",
    "title": "Novel CAR-T Therapy for B-Cell Lymphoma",
    "conditions": ["B-Cell Lymphoma", "Non-Hodgkin Lymphoma"],
    "inclusion_criteria": "Relapsed or refractory disease, CD19 positive",
    "exclusion_criteria": "Active infection, CNS involvement",
    "phase": "Phase 1"
  },
  {
    "id": "NCT004",
    "title": "Aspirin for Heart Disease Prevention",
    "conditions": ["Cardiovascular Disease", "Heart Disease"],
    "inclusion_criteria": "Age > 50, History of hypertension",
    "exclusion_criteria": "Bleeding disorders, Allergy to aspirin",
    "phase": "Phase 2"
  }
]